通过TFAM介导的线粒体生物生成,CRIP1抑制皮肤黑色素瘤的进展
Jianqiang Wu1, Lixia Chen2, Peijun Wen3
1Department of Dermatology, the Affiliated Panyu Central Hospital, Guangzhou Medical University, Guangzhou, 511400, China. wjqclx1993@163.com.
Scientific reports
|February 5, 2025
概括
富含氨酸的蛋白1 (CRIP1) 通过抑制线粒体生物发生抑制黑色素瘤细胞生长和扩散. 较低的CRIP1水平与预后不佳相关,这表明CRIP1是黑色素瘤的潜在治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 皮肤黑色素瘤转移导致患者死亡.
- 富含氨酸的蛋白1 (CRIP1) 与各种癌症有关,但其在黑色素瘤中的作用尚不清楚.
研究的目的:
- 研究CRIP1在黑色素瘤进展中的功能和机制.
- 评估CRIP1表达作为黑色素瘤患者的预后标志物.
主要方法:
- 对CRIP1表达和患者预后的生物信息分析.
- 在体外研究中使用具有CRIP1过度表达/敲击的黑色素瘤细胞系 (RT-qPCR,西部斑).
- 功能测试,线粒体生物生成评估 (OCR,mtDNA,ATP测试) 和TFAM相互作用研究.
主要成果:
- 黑色素瘤组织中CRIP1表达的减少与预后不佳相关.
- 在实验室中,CRIP1抑制了黑色素瘤细胞的增殖,迁移和侵入.
- 克里普1抑制TFAM介导的线粒体生物发生,影响细胞呼吸和ATP的产生.
结论:
- 通过抑制TFAM介导的线粒体生物发生,CRIP1在皮肤黑色素瘤中起到瘤抑制作用.
- CRIP1代表了改善黑色素瘤患者治疗结果的潜在治疗标.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
The Intrinsic Apoptotic Pathway
6.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
Mitochondrial Precursor Proteins
2.5K
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70 chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
Most of the mitochondrial...
2.5K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K


